CD8A and uterine cervix neoplasm: Meng et al. compared the number of CD8+ T cells and PD-L1 and PD-1 checkpoint expression in cervical tumor samples from patients treated with or without NACT; both CD8+ T-cell numbers and checkpoint expression were higher in patients previously treated with NACT [11].